What is Coeptis Therapeutics Holdings Days Payable?
Coeptis Therapeutics HoldingsCOEP +1.52%12 Days Payable is 1,695.22 as of Dec. 2025, which is 21% above its 10-year median of 1,395.90. GuruFocus rates COEP with a GF Score™ of 12/100. Among 705 Biotechnology companies, Coeptis Therapeutics Holdings ranks better than 90.21% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Coeptis Therapeutics Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Coeptis Therapeutics Holdings Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Coeptis Therapeutics Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Coeptis Therapeutics Holdings's Days Payable falls into.
Coeptis Therapeutics Holdings Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Coeptis Therapeutics Holdings (COEP) has a Days Payable of 1,695.22 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Coeptis Therapeutics Holdings and its competitors. This is 21% above median its historical median of 1,395.90. Over the past decade, Coeptis Therapeutics Holdings' Days Payable has ranged from 614.90 to 2,176.89. According to the industry distribution chart, Coeptis Therapeutics Holdings ranks #69 out of 705 companies in the Biotechnology industry, placing it in the top 9.8%.
Is Coeptis Therapeutics Holdings' Days Payable too high?
Coeptis Therapeutics Holdings' current Days Payable of 1,695.22 is 21% above median its 10-year median of 1,395.90. Over the past 10 years, this metric has ranged from a low of 614.90 to a high of 2,176.89. The Biotechnology industry median Days Payable is 113.36. Coeptis Therapeutics Holdings' value of 1,695.22 is 1395.4% above this industry median. Based on the distribution chart, Coeptis Therapeutics Holdings ranks #69 out of 705 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Coeptis Therapeutics Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Coeptis Therapeutics Holdings' Days Payable compare to ANIX and COYA?
According to the Biotechnology industry distribution chart, Coeptis Therapeutics Holdings ranks #69 out of 705 companies for Days Payable. This places Coeptis Therapeutics Holdings in the top 10% of its industry — outperforming the majority of peers. The industry median Days Payable is 113.36. Coeptis Therapeutics Holdings' value of 1,695.22 is 1395.4% above this benchmark. Historically, Coeptis Therapeutics Holdings' own Days Payable has ranged from 614.90 to 2,176.89 over the past decade. While the company's 10-year median is 1,395.90 vs. the industry median of 113.36, Coeptis Therapeutics Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.36, based on 705 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Coeptis Therapeutics Holdings's current Days Payable of 1,695.22 is 1395.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Coeptis Therapeutics Holdings and its competitors. For the Biotechnology industry, the median Days Payable is 113.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Coeptis Therapeutics Holdings's current Days Payable is 1,695.22, which is 21% above median its own 10-year median of 1,395.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coeptis Therapeutics Holdings stock overvalued right now?
Coeptis Therapeutics Holdings (COEP) has a current Days Payable of 1,695.22. The current Days Payable is 1,695.22, which is 21% above median its 10-year median of 1,395.90 and 1395.4% above the Biotechnology industry median of 113.36. Coeptis Therapeutics Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Coeptis Therapeutics Holdings (COEP), the current Days Payable is 1,695.22 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Coeptis Therapeutics Holdings Business Description
Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.
12GF Score
Get the complete analysis for COEP
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COEP has been successfully added to your 
